Jason Grebely
@jasongrebely
Followers
2K
Following
3K
Media
392
Statuses
2K
Prof @KirbyInstitute @UNSW | President @INHepSU | SE @ijdrugpolicy | #HCV #PWID | #ClinicalEpidemiology #PublicHealth
Sydney, Australia
Joined September 2015
Great to see this paper in press @LancetGastroHep Amazing leadership from Alison Marshall @KirbyInstitute to pull together this network. Thanks to our global collaborators, including John Ward & Lindsey Hiebert-Suwondo @GlobalHep, @JVLazarus, Andrew Scheibe, & Peter Vickerman.
An estimated 57 million people are living with chronic hepatitis C virus (#HCV) infection worldwide. Of 209 total countries & jurisdictions, new Kirby study published in @LancetGastroHep retrieved data from 160 (77%). Read full study here:
0
7
28
RT @ijdrugpolicy: 🚨Call for Papers🚨. The Special Issue accepts articles on innovative strategies and evidence-based implementation research….
0
12
0
Very proud of this paper from my wife @LiseLafferty and PhD student @MJxStowe (and others) on novel ways to engage community and early and mid-career researchers in networking at conferences reflecting on experiences from @INHepSU in INHSU 2022 in Glasgow. Amazing work!!.
Open Access: Co-creating and implementing a novel pre-conference event to promote #equity and #inclusivity among academic researchers and people who use drugs. MJ Stowe @HansfordLouise Rachel Halford, Jason Wallace @LiseLafferty.
0
4
25
RT @ijdrugpolicy: Save the date of the annual @ISSDrugPolicy conference in Montreal, Canada this year on June 19th to 21st. It’s going to….
0
7
0
RT @carlatreloar: As incoming co-editor in chief of.@ijdrugpolicy, @jasongrebely and I outline our plans - and pay homage to the amazing wo….
0
6
0
RT @NDARCNEWS: Can you help us? . We are looking for data for our global #prison review examining #bloodborne virus infections, drug use an….
0
5
0
RT @ijdrugpolicy: We want to thank Professor @AlisonRitter1 for all her hard work over the years with our journal. Professor Ritter joined….
0
12
0
RT @APSAD_DAR: Open Access - Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study….
0
3
0
RT @INHepSU: INHSU's Liv Dawson is at #WorldHepatitisSummit in Lisbon, where she'll be discussing Storytelling for Advocacy. INHSU Prisons….
0
6
0
RT @ijdrugpolicy: “Vaccination coverage among people who inject drugs: A systematic review” by Olivia Price et al (2024) via @ijdrugpolicy…….
0
2
0
RT @INHepSU: If you haven't seen, our board member @HansfordLouise is sharing stories in her feed of inspirational women as part of #Intern….
0
6
0
0
105
0
Great commentary by @DrSuziNielsen @MJxStowe @AlisonRitter1 on two recent papers in @ijdrugpolicy and emerging evidence on safer supply. I love their comment about the famous systematic review of randomised controlled trials of parachutes!
“In pursuit of safer supply: An emerging evidence base for medical and nonmedical models” by @DrSuziNielsen, MJ Stowe, & @AlisonRitter1 (2024) via @ijdrugpolicy…are healthcare providers supportive of safe supply in your region? . Link: #SafeSupply
0
1
8
Massive thanks to @MBG_SPHERE for the initial seed funding for the TEMPO Pilot Project which helped to catalyse the development of this program. Watch more about the TEMPO Pilot Project here from @conorashleigh:
What a long way @jasongrebely and his team have come in their point-of-care testing. Last year we published this story about the success of the program and now the program is being scaled-up even further.
0
1
4
Important scoping review by Shaleesa Ledlie, @Tara_Gomes, and colleagues highlighting the evidence on prescribed safer opioid supply.
“Prescribed safer opioid supply: A scoping review of the evidence” by Shaleesa Ledlie et al (2024) via @ijdrugpolicy…how do people dispute safer supply after looking at the evidence?! What’s your favorite part of the safer supply evidence? . Link:
0
0
4
@melkingsland @Njt14 @SophyShih @E_B_Cunningham @carlatreloar @LiseLafferty @chuckhendy @_GFontaine @GrimshawJeremy And also thanks to the >150 partners from community, service providers, policy makers, researchers, and industry who have contributed to the program to date. Thanks to @healthgovau for supporting the program. Read more about the program here:.
0
1
5
Thanks to Greg Dore, Andrew Lloyd, Susan Matthews, @melkingsland, @Njt14, Alison Marshall, @SophyShih, Richard Gray, @E_B_Cunningham, @carlatreloar, @LiseLafferty, Louise Causer, @chuckhendy, Philip Cunningham, @_GFontaine, and @GrimshawJeremy for their contributions.
1
3
4
Excited to embark on new research to understand what works and why with point-of-care #HCV testing.
Congratulations to the Kirby's @Jasongrebely &team who have been awarded $5M from @healthgovau MRFF for research that will enable the national scale up of point-of-care testing for #hepatitisC. @SophyShih | @E_B_Cunningham | @LiseLafferty | @Flinders .
4
5
32
RT @carlatreloar: New paper from Jake Rance, @jasongrebely and me: . Full article: The time of cure: hepatitis C treatment and the matter o….
0
6
0
RT @INHepSU: Join #INHSUEMCR & @CHERISHresearch for a webinar with @ali_jalali_ & @ShashiKapadiaMD. Learn:. ➡️Purpose & approach to economi….
0
11
0
RT @LancetGastroHep: New Health Policy - Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, a….
0
10
0